ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey.

Robert J Petrella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.